Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Oberg

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1972
X-ray diffraction studies of the structure of satellite tobacco necrosis virusK Akervall, B Strandberg, M G Rossmann, et al.
Biochemical Pharmacology|January 1, 1989
An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogsH Bazin, J Chattopadhyaya, R Datema, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1985
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipientsG Klintmalm, B Lönnqvist, B Oberg, et al.
Journal of Clinical Microbiology|May 29, 2001
Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infectionG Van den Bosch, G Locatelli, L Geerts, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitorsK Uberla, C Stahl-Hennig, D Böttiger, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitorsJ Balzarini, A Karlsson, A M Vandamme, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1977
Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphateB Eriksson, E Helgstrand, N G Johansson, et al.
Aging & Mental Health|January 30, 2003
The COPE index--a first stage assessment of negative impact, positive value and quality of support of caregiving in informal carers of older peopleK J McKee, I Philp, G Lamura, et al.
Virology|January 1, 1993
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptaseJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.
Science (New York, N.Y.)|September 1, 1978
Trisodium phosphonoformate, a new antiviral compoundE Helgstrand, B Eriksson, N G Johansson, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1972
X-ray diffraction studies of the structure of satellite tobacco necrosis virusK Akervall, B Strandberg, M G Rossmann, et al.
Biochemical Pharmacology|January 1, 1989
An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogsH Bazin, J Chattopadhyaya, R Datema, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1985
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipientsG Klintmalm, B Lönnqvist, B Oberg, et al.
Journal of Clinical Microbiology|May 29, 2001
Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infectionG Van den Bosch, G Locatelli, L Geerts, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitorsK Uberla, C Stahl-Hennig, D Böttiger, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitorsJ Balzarini, A Karlsson, A M Vandamme, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1977
Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphateB Eriksson, E Helgstrand, N G Johansson, et al.
Aging & Mental Health|January 30, 2003
The COPE index--a first stage assessment of negative impact, positive value and quality of support of caregiving in informal carers of older peopleK J McKee, I Philp, G Lamura, et al.
Virology|January 1, 1993
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptaseJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.
Science (New York, N.Y.)|September 1, 1978
Trisodium phosphonoformate, a new antiviral compoundE Helgstrand, B Eriksson, N G Johansson, et al.
Pageof 21